Calumet (CLMT) Cash & Equivalents (2022 - 2026)

Calumet (CLMT) has reported Cash & Equivalents for 5 consecutive years, with $138.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Equivalents rose 12.32% year-over-year to $138.6 million; the TTM figure through Mar 2026 stood at $138.6 million (up 12.32% YoY), while the FY2025 annual figure was $125.1 million, up 228.35% from the prior year.
• Cash & Equivalents climbed to $138.6 million in Q1 2026 per CLMT's latest filing, from $125.1 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $138.6 million in Q1 2026 and bottomed at $7.0 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $61.2 million across 5 years, with a median of $38.1 million in 2024.
• Annual changes were most pronounced in 2024 — Cash & Equivalents sank 83.57% — and 2025, when it jumped 1480.0%.
• Calumet's Cash & Equivalents stood at $35.2 million in 2022, then sank by 77.56% to $7.9 million in 2023, then surged by 382.28% to $38.1 million in 2024, then soared by 228.35% to $125.1 million in 2025, then grew by 10.79% to $138.6 million in 2026.
• Business Quant data shows CLMT's Cash & Equivalents at $138.6 million in Q1 2026, $125.1 million in Q4 2025, and $94.6 million in Q3 2025.